Here, we armed our VV with IL-27 and the results show that arming with IL-27 further enhances the antitumor effect of VVL-TD-RFP, leading to 100% tumor clearance and a long-term specific antitumor immune response in the DT6606 subcutaneous tumor model. Here, IL27 is linked to neoplasm.